Eletrophilic Chemistry of Tranilast Is Involved in Its Anti-Colitic Activity via Nrf2-HO-1 Pathway Activation

Tranilast (TRL), a synthetic derivative of a tryptophan metabolite, is an anti-allergic drug used to treat bronchial asthma. We investigated how TRL activated the nuclear factor-erythroid 2 p45-related factor 2 (Nrf2)-hemeoxygenase-1 (HO-1) pathway based on the electrophilic chemistry of the drug an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Seongkeun Jeong, Changyu Kang, Sohee Park, Sanghyun Ju, Jin-Wook Yoo, In-Soo Yoon, Hwayoung Yun, Yunjin Jung
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/d4c7830b0e65428d8b8d171c5bd527fb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d4c7830b0e65428d8b8d171c5bd527fb
record_format dspace
spelling oai:doaj.org-article:d4c7830b0e65428d8b8d171c5bd527fb2021-11-25T18:39:16ZEletrophilic Chemistry of Tranilast Is Involved in Its Anti-Colitic Activity via Nrf2-HO-1 Pathway Activation10.3390/ph141110921424-8247https://doaj.org/article/d4c7830b0e65428d8b8d171c5bd527fb2021-10-01T00:00:00Zhttps://www.mdpi.com/1424-8247/14/11/1092https://doaj.org/toc/1424-8247Tranilast (TRL), a synthetic derivative of a tryptophan metabolite, is an anti-allergic drug used to treat bronchial asthma. We investigated how TRL activated the nuclear factor-erythroid 2 p45-related factor 2 (Nrf2)-hemeoxygenase-1 (HO-1) pathway based on the electrophilic chemistry of the drug and whether TRL activity contributed to the treatment of rat colitis. In human colon carcinoma cells, TRL activated Nrf2, as represented by an increase in nuclear Nrf2 and induction of Nrf2-dependent luciferase and, subsequently, HO-1, a target gene product of Nrf2. TRL activation of Nrf2 and induction of HO-1 were completely prevented by chemical reduction of the electrophilic functional group (α, β-unsaturated carbonyl group) in the drug. In parallel, TRL was reactive with the nucleophilic thiol group in <i>N</i>-acetylcysteine, forming a covalent adduct. Moreover, TRL, but not reduced TRL, binds to Kelch-like ECH-associated protein 1 (KEAP1), releasing Nrf2. TRL administration ameliorated colonic damage and inflammation in rats with dinitrobenzene sulfonic acid-induced colitis, which was partly compromised by the chemical reduction of TRL or co-treatment with an HO-1 inhibitor. Our results suggest that TRL activated the Nrf2-HO-1 pathway via covalent binding to KEAP1, partly contributing to TRL amelioration in rat colitis.Seongkeun JeongChangyu KangSohee ParkSanghyun JuJin-Wook YooIn-Soo YoonHwayoung YunYunjin JungMDPI AGarticletranilastelectrophileNrf2HO-1colitisMedicineRPharmacy and materia medicaRS1-441ENPharmaceuticals, Vol 14, Iss 1092, p 1092 (2021)
institution DOAJ
collection DOAJ
language EN
topic tranilast
electrophile
Nrf2
HO-1
colitis
Medicine
R
Pharmacy and materia medica
RS1-441
spellingShingle tranilast
electrophile
Nrf2
HO-1
colitis
Medicine
R
Pharmacy and materia medica
RS1-441
Seongkeun Jeong
Changyu Kang
Sohee Park
Sanghyun Ju
Jin-Wook Yoo
In-Soo Yoon
Hwayoung Yun
Yunjin Jung
Eletrophilic Chemistry of Tranilast Is Involved in Its Anti-Colitic Activity via Nrf2-HO-1 Pathway Activation
description Tranilast (TRL), a synthetic derivative of a tryptophan metabolite, is an anti-allergic drug used to treat bronchial asthma. We investigated how TRL activated the nuclear factor-erythroid 2 p45-related factor 2 (Nrf2)-hemeoxygenase-1 (HO-1) pathway based on the electrophilic chemistry of the drug and whether TRL activity contributed to the treatment of rat colitis. In human colon carcinoma cells, TRL activated Nrf2, as represented by an increase in nuclear Nrf2 and induction of Nrf2-dependent luciferase and, subsequently, HO-1, a target gene product of Nrf2. TRL activation of Nrf2 and induction of HO-1 were completely prevented by chemical reduction of the electrophilic functional group (α, β-unsaturated carbonyl group) in the drug. In parallel, TRL was reactive with the nucleophilic thiol group in <i>N</i>-acetylcysteine, forming a covalent adduct. Moreover, TRL, but not reduced TRL, binds to Kelch-like ECH-associated protein 1 (KEAP1), releasing Nrf2. TRL administration ameliorated colonic damage and inflammation in rats with dinitrobenzene sulfonic acid-induced colitis, which was partly compromised by the chemical reduction of TRL or co-treatment with an HO-1 inhibitor. Our results suggest that TRL activated the Nrf2-HO-1 pathway via covalent binding to KEAP1, partly contributing to TRL amelioration in rat colitis.
format article
author Seongkeun Jeong
Changyu Kang
Sohee Park
Sanghyun Ju
Jin-Wook Yoo
In-Soo Yoon
Hwayoung Yun
Yunjin Jung
author_facet Seongkeun Jeong
Changyu Kang
Sohee Park
Sanghyun Ju
Jin-Wook Yoo
In-Soo Yoon
Hwayoung Yun
Yunjin Jung
author_sort Seongkeun Jeong
title Eletrophilic Chemistry of Tranilast Is Involved in Its Anti-Colitic Activity via Nrf2-HO-1 Pathway Activation
title_short Eletrophilic Chemistry of Tranilast Is Involved in Its Anti-Colitic Activity via Nrf2-HO-1 Pathway Activation
title_full Eletrophilic Chemistry of Tranilast Is Involved in Its Anti-Colitic Activity via Nrf2-HO-1 Pathway Activation
title_fullStr Eletrophilic Chemistry of Tranilast Is Involved in Its Anti-Colitic Activity via Nrf2-HO-1 Pathway Activation
title_full_unstemmed Eletrophilic Chemistry of Tranilast Is Involved in Its Anti-Colitic Activity via Nrf2-HO-1 Pathway Activation
title_sort eletrophilic chemistry of tranilast is involved in its anti-colitic activity via nrf2-ho-1 pathway activation
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/d4c7830b0e65428d8b8d171c5bd527fb
work_keys_str_mv AT seongkeunjeong eletrophilicchemistryoftranilastisinvolvedinitsanticoliticactivityvianrf2ho1pathwayactivation
AT changyukang eletrophilicchemistryoftranilastisinvolvedinitsanticoliticactivityvianrf2ho1pathwayactivation
AT soheepark eletrophilicchemistryoftranilastisinvolvedinitsanticoliticactivityvianrf2ho1pathwayactivation
AT sanghyunju eletrophilicchemistryoftranilastisinvolvedinitsanticoliticactivityvianrf2ho1pathwayactivation
AT jinwookyoo eletrophilicchemistryoftranilastisinvolvedinitsanticoliticactivityvianrf2ho1pathwayactivation
AT insooyoon eletrophilicchemistryoftranilastisinvolvedinitsanticoliticactivityvianrf2ho1pathwayactivation
AT hwayoungyun eletrophilicchemistryoftranilastisinvolvedinitsanticoliticactivityvianrf2ho1pathwayactivation
AT yunjinjung eletrophilicchemistryoftranilastisinvolvedinitsanticoliticactivityvianrf2ho1pathwayactivation
_version_ 1718410865166778368